Two specialized portfolios covering next-generation antibody therapeutics and oligonucleotide, peptide, and RNA modalities — from discovery through manufacturing, across the US, Europe, and Asia.
Discovery, engineering, and development of next-generation antibody therapeutics.
Oligonucleotides, peptides, and RNA therapeutics — discovery through manufacturing.
Sponsorship, thought-leadership, and integrated campaigns across the Antibody Engineering and TIDES & RNA portfolios.